0,1
nan,
57-56-7,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man TDLo intravenous 40mg/kg (40mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 122, Pg. 110, 1958.
mouse LD50 intraperitoneal 123mg/kg (123mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 122, Pg. 110, 1958.
mouse LD50 intravenous 126mg/kg (126mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 122, Pg. 110, 1958.
mouse LD50 oral 176mg/kg (176mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 122, Pg. 110, 1958.
mouse LD50 subcutaneous 105mg/kg (105mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 119, Pg. 444, 1957.
rat LD50 intraperitoneal 140mg/kg (140mg/kg)   Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. Vol. 257, Pg. 296, 1967.
rat LD50 subcutaneous 140mg/kg (140mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 645, 1968."
112398-08-0,
1950/2/2,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 410mg/kg (410mg/kg)   Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 281, 1970.
mouse LD50 subcutaneous 4400mg/kg (4400mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 21, Pg. 2117, 1979.
rabbit LD50 subcutaneous 7200ug/kg (7.2mg/kg) GASTROINTESTINAL: ""HYPERMOTILITY, DIARRHEA""

SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 687, 1984.
rat LD50 intraperitoneal 54mg/kg (54mg/kg) GASTROINTESTINAL: ""HYPERMOTILITY, DIARRHEA""

SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE

SKIN AND APPENDAGES (SKIN): HAIR: OTHER Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 687, 1984.
rat LD50 oral > 3gm/kg (3000mg/kg)   Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 687, 1984.
rat LD50 subcutaneous 14mg/kg (14mg/kg)   Toxicology and Applied Pharmacology. Vol. 8, Pg. 250, 1966.
women TDLo multiple routes 4759ug/kg/18D (4.759mg/kg) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED Intensive Care Medicine. Vol. 21, Pg. 238, 1995."
439-14-5,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 parenteral > 800mg/kg (800mg/kg)   Drugs in Japan Vol. -, Pg. 500, 1995.
infant TDLo intravenous 150ug/kg (0.15mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"" British Medical Journal. Vol. 2, Pg. 298, 1977.
mammal (species unspecified) LD50 oral 500mg/kg (500mg/kg)   Doklady Akademii Nauk SSSR. Proceedings of the Academy of Sciences of the USSR. For English translation, see DBIOAM and DKBSAS. Vol. 320, Pg. 242, 1991.
mammal (species unspecified) LD50 unreported 110mg/kg (110mg/kg)   Pharmaceutical Chemistry Journal Vol. 25, Pg. 193, 1991.
man TDLo intravenous 71ug/kg/1M-C (0.071mg/kg) VASCULAR: OTHER CHANGES Drug Intelligence and Clinical Pharmacy. Vol. 17, Pg. 125, 1983.
man TDLo intravenous 143ug/kg (0.143mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) JAMA, Journal of the American Medical Association. Vol. 238, Pg. 1052, 1977.
man TDLo oral 143ug/kg (0.143mg/kg) SENSE ORGANS AND SPECIAL SENSES: DIPLOPIA: EYE

SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE British Journal of Clinical Pharmacology. Vol. 1, Pg. 335, 1974.
mouse LD50 intramuscular 65mg/kg (65mg/kg)   European Journal of Pharmacology. Vol. 13, Pg. 150, 1971.
mouse LD50 intraperitoneal 37mg/kg (37mg/kg)   Strahlentherapie. Vol. 127, Pg. 245, 1965.
mouse LD50 intravenous 25mg/kg (25mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 2180, 1981.
mouse LD50 oral 48mg/kg (48mg/kg)   Pharmaceutical Chemistry Journal Vol. 17, Pg. 30, 1983.
mouse LD50 parenteral 80mg/kg (80mg/kg)   United States Patent Document. Vol. #4371536,
mouse LD50 rectal 500mg/kg (500mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 2226, 1992.
mouse LD50 skin 800mg/kg (800mg/kg)   Anesteziologiya i Reanimatologiya. Vol. (4), Pg. 57, 1980.
mouse LD50 subcutaneous 800mg/kg (800mg/kg)   United States Patent Document. Vol. #3966793,
mouse LD50 unreported 140mg/kg (140mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Pharmaceutical Chemistry Journal Vol. 18, Pg. 266, 1984.
rabbit LD50 intravenous 9mg/kg (9mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE International Journal of Neuropharmacology. Vol. 5, Pg. 305, 1966.
rabbit LD50 oral 328mg/kg (328mg/kg)   Current Therapeutic Research, Clinical & Experimental. Vol. 7, Pg. 590, 1965.
rat LD50 intraperitoneal 46500ug/kg (46.5mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992.
rat LD50 intravenous 32mg/kg (32mg/kg)   Current Therapeutic Research, Clinical & Experimental. Vol. 7, Pg. 590, 1965.
rat LD50 oral 249mg/kg (249mg/kg)   Drugs in Japan Vol. -, Pg. 500, 1995.
rat LD50 parenteral 131mg/kg (131mg/kg)   Drugs in Japan Vol. -, Pg. 500, 1995.
rat LD50 rectal 600mg/kg (600mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 34, Pg. 2226, 1992.
rat LD50 subcutaneous 6350ug/kg (6.35mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992.
women TDLo intramuscular 181ug/kg (0.181mg/kg) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

BEHAVIORAL: GENERAL ANESTHETIC

CARDIAC: CHANGE IN RATE British Medical Journal. Vol. 1, Pg. 144, 1977.
women TDLo oral 5mg/kg (5mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) British Journal of Obstetrics and Gynaecology. Vol. 100, Pg. 185, 1993."
564-25-0,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 100mg/kg (100mg/kg)   Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979.
dog LD50 oral > 500mg/kg (500mg/kg)   Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979.
mouse LD50 intraperitoneal 410mg/kg (410mg/kg)   Giornale Italiano di Chemioterapia. Italian Journal of Chemotherapy. Vol. 17, Pg. 276, 1970.
mouse LD50 intravenous 241mg/kg (241mg/kg)   Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979.
mouse LD50 oral 1870mg/kg (1870mg/kg)   Giornale Italiano di Chemioterapia. Italian Journal of Chemotherapy. Vol. 17, Pg. 276, 1970.
rat LD50 intraperitoneal 378mg/kg (378mg/kg)   Therapie. Vol. 23, Pg. 575, 1968.
rat LD50 intravenous 228mg/kg (228mg/kg)   Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979.
rat LD50 oral > 2gm/kg (2000mg/kg)   Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979.
women TDLo oral 68mg/kg/24D-I (68mg/kg)   Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991.
women TDLo oral 68mg/kg/24D-I (68mg/kg)   Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991.
women TDLo oral 68mg/kg/24D-I (68mg/kg) MUSCULOSKELETAL: JOINTS Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991."
93106-60-6,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 200mg/kg (200mg/kg)   VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.
mouse LD50 oral 4336mg/kg (4336mg/kg)   VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.
rabbit LD50 oral 500mg/kg (500mg/kg)   VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987.
rat LD50 oral 5gm/kg (5000mg/kg)   VMR, Veterinary Medical Review. Vol. 2, Pg. 87, 1987."
139-91-3,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 1gm/kg (1000mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION

BEHAVIORAL: ANTIPSYCHOTIC Journal of Pharmacy and Pharmacology. Vol. 16, Pg. 663, 1964.
mouse LD50 intravenous 400mg/kg (400mg/kg)   Farmaco, Edizione Scientifica. Vol. 19, Pg. 269, 1964.
mouse LD50 oral 600mg/kg (600mg/kg)   Farmaco, Edizione Scientifica. Vol. 19, Pg. 269, 1964."
67-20-9,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
chicken LD50 oral 53mg/kg (53mg/kg)   Journal of Nutrition. Vol. 112, Pg. 1741, 1982.
human TDLo oral 80mg/kg (80mg/kg) BEHAVIORAL: ATAXIA

PERIPHERAL NERVE AND SENSATION: RECORDING FROM PERIPHERAL MOTOR NERVE Archives of Neurology Vol. 18, Pg. 680, 1968.
human TDLo unreported 60mg/kg (60mg/kg) KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION British Medical Journal. Vol. 2, Pg. 1044, 1976.
mammal (species unspecified) LDLo oral 250mg/kg (250mg/kg)   Bollettino Chimico Farmaceutico. Vol. 102, Pg. 505, 1963.
man TDLo oral 29mg/kg/20D-I (29mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE

BRAIN AND COVERINGS: INCREASED INTRACRANIAL PRESSURE Drug Intelligence and Clinical Pharmacy. Vol. 22, Pg. 345, 1988.
man TDLo oral 40mg/kg/2W-I (40mg/kg) KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS

KIDNEY, URETER, AND BLADDER: PROTEINURIS

BLOOD: CHANGES IN LEUCOCYTE (WBC) COUNT Lancet. Vol. 348, Pg. 1177, 1996.
mouse LD50 intraperitoneal 100mg/kg (100mg/kg)   National Technical Information Service. Vol. AD277-689,
mouse LD50 oral 360mg/kg (360mg/kg)   Journal of Medicinal Chemistry. Vol. 16, Pg. 312, 1973.
rat LD50 intraperitoneal 112mg/kg (112mg/kg)   Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 303, 1970.
rat LD50 oral 604mg/kg (604mg/kg)   Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 303, 1970.
women TDLo oral 24mg/kg (24mg/kg) BLOOD: OTHER HEMOLYSIS WITH OR WITHOUT ANEMIA American Journal of Clinical Pathology. Vol. 58, Pg. 408, 1972.
women TDLo oral 42mg/kg/6W-I (42mg/kg) LIVER: ""JAUNDICE, OTHER OR UNCLASSIFIED""

LIVER: ""HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE""

LIVER: LIVER FUNCTION TESTS IMPAIRED Medical Journal of Australia. Vol. 156, Pg. 347, 1992.
women TDLo oral 365mg/kg/1Y-I (365mg/kg) LIVER: LIVER FUNCTION TESTS IMPAIRED

LUNGS, THORAX, OR RESPIRATION: FIBROSIS (INTERSTITIAL)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA Postgraduate Medical Journal. Vol. 73, Pg. 519, 1997."
59-87-0,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 96mg/kg (96mg/kg)   Journal of Medicinal Chemistry. Vol. 10, Pg. 530, 1967.
mouse LD50 oral 249mg/kg (249mg/kg)   Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol. 74, Pg. 43, 1980.
mouse LD50 subcutaneous 753mg/kg (753mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 102, Pg. 185, 1951.
rat LD50 oral 590mg/kg (590mg/kg)   JAMA, Journal of the American Medical Association. Vol. 133, Pg. 299, 1947.
rat LD50 subcutaneous 3gm/kg (3000mg/kg)   JAMA, Journal of the American Medical Association. Vol. 133, Pg. 299, 1947.
rat LDLo intraperitoneal 150mg/kg (150mg/kg)   Biochemical Pharmacology. Vol. 13, Pg. 285, 1964."
67-45-8,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
chicken LDLo oral 150mg/kg (150mg/kg)   Compilation of LD50 Values of New Drugs.
mammal (species unspecified) LD50 unreported 178mg/kg (178mg/kg)   Journal of Toxicology and Environmental Health. Vol. 51, Pg. 89, 1997.
man TDLo oral 11mg/kg (11mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BLOOD: EOSINOPHILIA American Review of Respiratory Disease. Vol. 105, Pg. 823, 1972.
mouse LD50 intraperitoneal 300mg/kg (300mg/kg)   Progress in Medical Chemistry. Vol. 5, Pg. 320, 1967.
mouse LD50 oral 1782mg/kg (1782mg/kg)   Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol. 74, Pg. 43, 1980.
mouse LD50 unreported 1150mg/kg (1150mg/kg)   Journal of Medicinal Chemistry. Vol. 14, Pg. 301, 1971.
rat LD50 oral 2336mg/kg (2336mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971."
73231-34-2,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 100mg/kg (100mg/kg)   Drugs of the Future. Vol. 7, Pg. 172, 1982."
85721-33-1,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
man LDLo oral 5714ug/kg/2D- (5.714mg/kg) LIVER: LIVER FUNCTION TESTS IMPAIRED

BEHAVIORAL: COMA

LIVER: ""JAUNDICE, OTHER OR UNCLASSIFIED"" Lancet. Vol. 343, Pg. 738, 1994.
man TDLo oral 21mg/kg/3D-I (21mg/kg) KIDNEY, URETER, AND BLADDER: HEMATURIA

KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED

KIDNEY, URETER, AND BLADDER: PROTEINURIS Annals of Pharmacotherpy. Vol. 29, Pg. 84, 1995.
man TDLo oral 21429ug/kg/3D (21.429mg/kg) BEHAVIORAL: TOXIC PSYCHOSIS

BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS"" Annals of Pharmacotherpy. Vol. 26, Pg. 930, 1992.
man TDLo oral 129mg/kg/6D-I (129mg/kg) BEHAVIORAL: REGIDITY Journal of Clinical Psychiatry. Vol. 54, Pg. 115, 1993.
man TDLo oral 200mg/kg (200mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: TREMOR

GASTROINTESTINAL: OTHER CHANGES Annals of Pharmacotherpy. Vol. 28, Pg. 805, 1994.
mouse LD50 intraperitoneal 1165mg/kg (1165mg/kg)   Ensho. Japanese Journal of Inflammation. Vol. 11, Pg. 343, 1991.
mouse LD50 intravenous 122mg/kg (122mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Korean Journal of Toxicology. Vol. 8, Pg. 161, 1993.
mouse LD50 oral 5gm/kg (5000mg/kg)   Journal of Medicinal Chemistry. Vol. 33, Pg. 1344, 1990.
mouse LD50 subcutaneous > 1gm/kg (1000mg/kg)   Zhongguo Yaoxue Zazhi. Chinese Pharmacuetical Journal. Vol. 27, Pg. 297, 1992.
rat LD50 intravenous 207mg/kg (207mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Korean Journal of Toxicology. Vol. 8, Pg. 161, 1993.
rat LD50 oral > 2gm/kg (2000mg/kg)   Zhongguo Yaoxue Zazhi. Chinese Pharmacuetical Journal. Vol. 27, Pg. 297, 1992.
rat LD50 subcutaneous > 1gm/kg (1000mg/kg)   Zhongguo Yaoxue Zazhi. Chinese Pharmacuetical Journal. Vol. 27, Pg. 297, 1992.
women TDLo multiple routes 40mg/kg/6D-I (40mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE""

SKIN AND APPENDAGES (SKIN): ""DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE"" Acta Clinica Belgica. Vol. 49, Pg. 173, 1994.
women TDLo oral 10mg/kg (10mg/kg)   Allergy. Vol. 50(Suppl,
women TDLo oral 10mg/kg (10mg/kg) BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS""

GASTROINTESTINAL: NAUSEA OR VOMITING Allergy. Vol. 50(Suppl,
women TDLo oral 40mg/kg/2D-I (40mg/kg)   American Journal of Medicine. Vol. 87, Pg. 589, 1989.
women TDLo oral 40mg/kg/2D-I (40mg/kg) BLOOD: EOSINOPHILIA

BEHAVIORAL: HEADACHE American Journal of Medicine. Vol. 87, Pg. 589, 1989.
women TDLo oral 135mg/kg/3D-I (135mg/kg) KIDNEY, URETER, AND BLADDER: ""CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"" Archives of Internal Medicine. Vol. 153, Pg. 1258, 1993.
women TDLo oral 280mg/kg/2W-I (280mg/kg) KIDNEY, URETER, AND BLADDER: ""CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)""

KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITIS

SKIN AND APPENDAGES (SKIN): ""DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE"" American Journal of Kidney Diseases. Vol. 22, Pg. 598, 1993."
nan,
443-48-1,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo oral 39600mg/kg/4W (39600mg/kg) PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE

SENSE ORGANS AND SPECIAL SENSES: CHANGE IN FUNCTION: TASTE

BEHAVIORAL: HEADACHE International Journal of Clinical Pharmacology Research. Vol. 19, Pg. 83, 1999.
man TDLo oral 3570ug/kg/D (3.57mg/kg)   JAMA, Journal of the American Medical Association. Vol. 193, Pg. 1128, 1965.
man TDLo oral 3570ug/kg/D (3.57mg/kg) LIVER: OTHER CHANGES

LIVER: ""JAUNDICE, OTHER OR UNCLASSIFIED"" JAMA, Journal of the American Medical Association. Vol. 193, Pg. 1128, 1965.
man TDLo oral 1030mg/kg/8W (1030mg/kg) PERIPHERAL NERVE AND SENSATION: STRUCTURAL CHANGE IN NERVE OR SHEATH

PERIPHERAL NERVE AND SENSATION: PARESTHESIS British Medical Journal. Vol. 2, Pg. 610, 1977.
mouse LD50 intraperitoneal 870mg/kg (870mg/kg)   Polish Journal of Pharmacology and Pharmacy. Vol. 42, Pg. 471, 1990.
mouse LD50 oral 3800mg/kg (3800mg/kg)   Journal of Medicinal Chemistry. Vol. 20, Pg. 1522, 1977.
mouse LD50 subcutaneous 3640mg/kg (3640mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 1089, 1974.
rat LD50 oral 3gm/kg (3000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: CYANOSIS Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 1089, 1974.
women TDLo intravenous 100mg/kg/5D-I (100mg/kg) BEHAVIORAL: IRRITABILITY

BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS""

BEHAVIORAL: TOXIC PSYCHOSIS American Journal of Psychiatry. Vol. 154, Pg. 1169, 1997.
women TDLo oral 12mg/kg (12mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: TREMOR British Medical Journal. Vol. 292, Pg. 174, 1986.
women TDLo oral 40mg/kg (40mg/kg) BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS"" Southern Medical Journal. Vol. 78, Pg. 627, 1985."
768-94-5,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 245mg/kg (245mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: TREMOR Drugs of the Future. Vol. 5, Pg. 557, 1980.
mouse LD50 oral 700mg/kg (700mg/kg)   British UK Patent Application. Vol. #2070004,
quail LD50 oral > 316mg/kg (316mg/kg)   Ecotoxicology and Environmental Safety. Vol. 6, Pg. 149, 1982.
rat LD50 intraperitoneal 223mg/kg (223mg/kg)   British UK Patent Application. Vol. #2070004,
rat LD50 oral 900mg/kg (900mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: TREMOR Journal de Pharmacologie. Vol. 9, Pg. 121, 1978."
57-62-5,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 150mg/kg (150mg/kg)   ""Handbook of Toxicology,"" 4 vols., Philadelphia, W.B. Saunders Co., 1956-59Vol. 5, Pg. 52, 1959.
dog LD50 oral 750mg/kg (750mg/kg)   Antimicrobial Agents Annual. Vol. -, Pg. 595, 1960.
guinea pig LDLo intraperitoneal 1800mg/kg (1800mg/kg)   Antibiotiki. Vol. 20, Pg. 793, 1975.
mouse LD50 intracrebral 48mg/kg (48mg/kg) BEHAVIORAL: EXCITEMENT

BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS""

MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES Chemotherapy Vol. 26, Pg. 196, 1980.
mouse LD50 intravenous 134mg/kg (134mg/kg)   Antibiotics and Chemotherapy Vol. 6, Pg. 623, 1956.
mouse LD50 oral 1500mg/kg (1500mg/kg)   Antimicrobial Agents Annual. Vol. -, Pg. 595, 1960.
mouse LDLo intraperitoneal 192mg/kg (192mg/kg)   Compilation of LD50 Values of New Drugs.
mouse LDLo subcutaneous 3gm/kg (3000mg/kg)   Antibiotics and Chemotherapy Vol. 6, Pg. 623, 1956.
rat LD50 intravenous 118mg/kg (118mg/kg)   Antibiotics and Chemotherapy Vol. 6, Pg. 623, 1956.
rat LDLo intraperitoneal 335mg/kg (335mg/kg)   Compilation of LD50 Values of New Drugs.
rat LDLo oral 3gm/kg (3000mg/kg)   Journal of Agricultural and Food Chemistry. Vol. 17, Pg. 497, 1969."
129138-58-5,
2437-29-8,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LDLo oral 50mg/kg (50mg/kg)   Archives of Toxicology. Vol. 56, Pg. 43, 1984.
rat LD skin > 2gm/kg (2000mg/kg)   Archives of Toxicology. Vol. 56, Pg. 43, 1984.
rat LD50 oral 275mg/kg (275mg/kg) GASTROINTESTINAL: ""HYPERMOTILITY, DIARRHEA""

GASTROINTESTINAL: OTHER CHANGES

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) Archives of Toxicology. Vol. 56, Pg. 43, 1984."
23696-28-8,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 oral 3316mg/kg (3316mg/kg)   Cesko-Slovenska Farmacie. Vol. 30, Pg. 26, 1981.
rat LD50 oral 1717mg/kg (1717mg/kg)   Cesko-Slovenska Farmacie. Vol. 30, Pg. 26, 1981."
154-21-2,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 intraperitoneal 1800mg/kg (1800mg/kg) BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS

BLOOD: OTHER CHANGES Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 35(2), Pg. 40, 1990.
mouse LD50 intraperitoneal 1gm/kg (1000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Antimicrobial Agents and Chemotherapy Vol. -,
mouse LD50 intravenous 214mg/kg (214mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 7, Pg. 913, 1965.
mouse LD50 oral 13900mg/kg (13900mg/kg) BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS

BLOOD: OTHER CHANGES Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 35(2), Pg. 40, 1990.
rabbit LDLo intramuscular 200ug/kg (0.2mg/kg)   Recueil de Medecine Veterinaire. Vol. 156, Pg. 915, 1980.
rat LD50 intraperitoneal 1900mg/kg (1900mg/kg) BLOOD: OTHER CHANGES

BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS Antibiotiki i Khimioterapiya. Antibiotics and Chemotherapy. Vol. 35(2), Pg. 40, 1990.
rat LD50 oral 1gm/kg (1000mg/kg)   ""Antibiotics: Origin, Nature, and Properties,"" Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 186, 1978.
rat LD50 subcutaneous 9778mg/kg (9778mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971."
50-53-3,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 subcutaneous > 10mg/kg (10mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961.
cat LDLo oral 100mg/kg (100mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

GASTROINTESTINAL: NAUSEA OR VOMITING Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 561, 1976.
child LDLo oral 37500ug/kg (37.5mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: COMA New England Journal of Medicine. Vol. 256, Pg. 527, 1957.
dog LD50 intravenous 30mg/kg (30mg/kg) BLOOD: HEMORRHAGE

LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA

LUNGS, THORAX, OR RESPIRATION: EMPHYSEMA Archives Internationales de Pharmacodynamie et de Therapie. Vol. 118, Pg. 358, 1959.
dog LD50 subcutaneous > 20mg/kg (20mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961.
dog LDLo oral 250mg/kg (250mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: REGIDITY Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 561, 1976.
guinea pig LD50 intraperitoneal 87mg/kg (87mg/kg)   Medicina Experimentalis. Vol. 8, Pg. 237, 1963.
guinea pig LDLo oral 250mg/kg (250mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

GASTROINTESTINAL: NAUSEA OR VOMITING Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 561, 1976.
human TDLo oral 8570ug/kg/12D (8.57mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: TREMOR

BEHAVIORAL: WAKEFULNESS Arzneimittel-Forschung. Drug Research. Vol. 22, Pg. 93, 1972.
infant TDLo oral 20mg/kg (20mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION American Journal of Diseases of Children. Vol. 130, Pg. 507, 1976.
mammal (species unspecified) LD50 oral 500mg/kg (500mg/kg) BEHAVIORAL: ANTICONVULSANT

BEHAVIORAL: ALTERATION OF CLASSICAL CONDITIONING Journal of Medicinal Chemistry. Vol. 8, Pg. 836, 1965.
man TDLo oral 8900ug/kg (8.9mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA American Journal of Emergency Medicine. Vol. 14, Pg. 467, 1996.
man TDLo oral 217mg/kg/19D (217mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE""

BLOOD: AGRANULOCYTOSIS Journal of Clinical Psychiatry. Vol. 46, Pg. 341, 1985.
monkey LD50 subcutaneous > 5mg/kg (5mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961.
mouse LC50 inhalation 209mg/m3/2H (209mg/m3) CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BEHAVIORAL: MUSCLE WEAKNESS

BLOOD: LEUKOPENIA Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. Vol. 10, Pg. 73, 1968.
mouse LD50 intraperitoneal 14mg/kg (14mg/kg)   Farmaco, Edizione Scientifica. Vol. 14, Pg. 269, 1959.
mouse LD50 intravenous 16mg/kg (16mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: REGIDITY Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961.
mouse LD50 oral 135mg/kg (135mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Archives Internationales de Pharmacodynamie et de Therapie. Vol. 118, Pg. 358, 1959.
mouse LD50 subcutaneous 33mg/kg (33mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: ATAXIA Arzneimittel-Forschung. Drug Research. Vol. 11, Pg. 932, 1961.
mouse LD50 unreported 82500ug/kg (82.5mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 53, Pg. 2S, 1957.
mouse LDLo intramuscular 300mg/kg (300mg/kg)   Therapie. Vol. 15, Pg. 1064, 1960.
rabbit LD50 intravenous 16mg/kg (16mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 120, Pg. 450, 1959.
rat LC50 inhalation 209mg/m3/2H (209mg/m3) CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BLOOD: LEUKOPENIA

BEHAVIORAL: MUSCLE WEAKNESS Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. Vol. 10, Pg. 73, 1968.
rat LD50 intraperitoneal 137mg/kg (137mg/kg)   German Offenlegungsschrift Patent Document. Vol. #2350222,
rat LD50 intravenous 23mg/kg (23mg/kg)   Farmaco, Edizione Pratica. Vol. 26, Pg. 585, 1971.
rat LD50 oral 142mg/kg (142mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 261, 1968.
rat LD50 subcutaneous 75mg/kg (75mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 56, Pg. 377, 1960.
women TDLo oral 200ug/kg (0.2mg/kg) LIVER: ""JAUNDICE, OTHER OR UNCLASSIFIED""

BEHAVIORAL: SLEEP New York State Journal of Medicine. Vol. 57, Pg. 1922, 1957.
women TDLo oral 16800ug/kg/3W (16.8mg/kg) BLOOD: AGRANULOCYTOSIS Postgraduate Medical Journal. Vol. 69, Pg. 885, 1993.
women TDLo oral 166mg/kg/18D- (166mg/kg) BLOOD: OTHER CHANGES

BLOOD: OTHER HEMOLYSIS WITH OR WITHOUT ANEMIA Postgraduate Medical Journal. Vol. 53, Pg. 278, 1977.
women TDLo oral 240mg/kg/30D- (240mg/kg) BLOOD: AGRANULOCYTOSIS

BLOOD: CHANGES IN LEUCOCYTE (WBC) COUNT Journal of Clinical Psychiatry. Vol. 46, Pg. 341, 1985.
women TDLo oral 240mg/kg/30D (240mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE""

BLOOD: AGRANULOCYTOSIS Journal of Clinical Psychiatry. Vol. 46, Pg. 341, 1985."
56-75-7,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo unreported 250mg/kg/10D (250mg/kg) BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE

BLOOD: HEMORRHAGE

LIVER: OTHER CHANGES Clinical Pediatrics Vol. 14, Pg. 499, 1975.
dog LD intramuscular > 101mg/kg (101mg/kg)   Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949.
dog LD oral > 300mg/kg (300mg/kg)   Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949.
dog LDLo intravenous 150mg/kg (150mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION Journal of Bacteriology. Vol. 55, Pg. 425, 1948.
guinea pig LD50 intravenous 560mg/kg (560mg/kg)   Farmaco, Edizione Scientifica. Vol. 9, Pg. 21, 1954.
guinea pig LD50 oral 500mg/kg (500mg/kg)   Farmaco, Edizione Scientifica. Vol. 10, Pg. 3, 1955.
infant LDLo intravenous 30mg/kg/3D-I (30mg/kg) CARDIAC: CARDIAC OUTPUT

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION Journal of Pediatrics. Vol. 103, Pg. 487, 1983.
infant LDLo unreported 200mg/kg/4D-I (200mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE""

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BLOOD: EOSINOPHILIA Lancet. Vol. 1, Pg. 555, 1986.
infant TDLo intramuscular 250mg/kg/2D (250mg/kg) VASCULAR: CHANGE IN PLASMA OR BLOOD VALUME New England Journal of Medicine. Vol. 262, Pg. 787, 1960.
infant TDLo oral 440mg/kg (440mg/kg)   JAMA, Journal of the American Medical Association. Vol. 234, Pg. 149, 1975.
infant TDLo oral 440mg/kg (440mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: OTHER CHANGES JAMA, Journal of the American Medical Association. Vol. 234, Pg. 149, 1975.
mouse LD50 intraperitoneal 1100mg/kg (1100mg/kg)   Dissertationes Pharmaceuticae. Vol. 14, Pg. 21, 1962.
mouse LD50 intravenous 110mg/kg (110mg/kg) BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949.
mouse LD50 oral 1500mg/kg (1500mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955.
mouse LD50 subcutaneous 400mg/kg (400mg/kg)   ""Antibiotics: Origin, Nature, and Properties,"" Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 493, 1978.
rabbit LD50 intravenous 117mg/kg (117mg/kg)   Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949.
rat LD50 intraperitoneal 1811mg/kg (1811mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
rat LD50 intravenous 171mg/kg (171mg/kg)   Journal of Clinical Investigation. Vol. 28, Pg. 943, 1949.
rat LD50 oral 2500mg/kg (2500mg/kg)   Farmaco, Edizione Scientifica. Vol. 10, Pg. 3, 1955.
rat LD50 subcutaneous 5gm/kg (5000mg/kg) GASTROINTESTINAL: ""HYPERMOTILITY, DIARRHEA"" Toxicology and Applied Pharmacology. Vol. 9, Pg. 445, 1966.
women LDLo oral 400mg/kg (400mg/kg) BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

VASCULAR: SHOCK JAMA, Journal of the American Medical Association. Vol. 234, Pg. 149, 1975."
330-95-0,
70458-96-7,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mammal (species unspecified) LD50 oral > 4gm/kg (4000mg/kg)   Journal of Medicinal Chemistry. Vol. 32, Pg. 671, 1989.
man TDLo oral 94mg/kg/13D-I (94mg/kg) MUSCULOSKELETAL: OTHER CHANGES New Zealand Medical Journal. Vol. 96, Pg. 590, 1983.
mouse LD50 intramuscular 470mg/kg (470mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Chemotherapy Vol. 29(Suppl,
mouse LD50 intraperitoneal 1064mg/kg (1064mg/kg)   Ensho. Japanese Journal of Inflammation. Vol. 11, Pg. 343, 1991.
mouse LD50 intravenous 220mg/kg (220mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Chemotherapy Vol. 29(Suppl,
mouse LD50 oral 4gm/kg (4000mg/kg)   Journal of Medicinal Chemistry. Vol. 30, Pg. 2163, 1987.
mouse LD50 subcutaneous > 1500mg/kg (1500mg/kg)   Yakkyoku. Pharmacy. Vol. 35, Pg. 1625, 1984.
rat LD50 intramuscular > 500mg/kg (500mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Chemotherapy Vol. 29(Suppl,
rat LD50 intravenous 245mg/kg (245mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Chemotherapy Vol. 29(Suppl,
rat LD50 oral > 4gm/kg (4000mg/kg)   Yakkyoku. Pharmacy. Vol. 35, Pg. 1625, 1984.
rat LD50 subcutaneous > 1500mg/kg (1500mg/kg)   Yakkyoku. Pharmacy. Vol. 35, Pg. 1625, 1984.
women TDLo oral 48mg/kg/2D-I (48mg/kg) LIVER: LIVER FUNCTION TESTS IMPAIRED

LIVER: ""HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL""

BEHAVIORAL: MUSCLE WEAKNESS Medical Journal of Australia. Vol. 159, Pg. 423, 1993.
women TDLo oral 48mg/kg/2D-I (48mg/kg) MUSCULOSKELETAL: JOINTS

BEHAVIORAL: MUSCLE WEAKNESS

LIVER: ""HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL"" Medical Journal of Australia. Vol. 159, Pg. 423, 1993."
4812-40-2,
18559-94-9,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
child TDLo oral 600ug/kg (0.6mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING Human & Experimental Toxicology. Vol. 12, Pg. 397, 1993.
child TDLo oral 1700ug/kg (1.7mg/kg)   American Journal of Emergency Medicine. Vol. 12, Pg. 64, 1994.
child TDLo oral 1700ug/kg (1.7mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP American Journal of Emergency Medicine. Vol. 12, Pg. 64, 1994.
child TDLo oral 1850ug/kg (1.85mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: EXCITEMENT

CARDIAC: CHANGE IN RATE British Medical Journal. Vol. 282, Pg. 1932, 1981.
human TDLo intravenous 6ug/kg (0.006mg/kg) CARDIAC: CHANGE IN RATE

VASCULAR: CHANGE IN PLASMA OR BLOOD VALUME

CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) British Medical Journal. Vol. 1, Pg. 365, 1976.
man TCLo inhalation 36ug/kg/6H (0.036mg/kg) BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS""

BEHAVIORAL: IRRITABILITY British Medical Journal. Vol. 292, Pg. 1430, 1986.
man TDLo oral 5714ug/kg (5.714mg/kg)   Annals of Emergency Medicine. Vol. 22, Pg. 1474, 1993.
man TDLo oral 5714ug/kg (5.714mg/kg) CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP

BEHAVIORAL: TREMOR Annals of Emergency Medicine. Vol. 22, Pg. 1474, 1993.
mouse LD50 intraperitoneal 167mg/kg (167mg/kg)   Veterinary and Human Toxicology. Vol. 39, Pg. 214, 1997.
mouse LD50 intravenous 48700ug/kg (48.7mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 193, 1973.
mouse LD50 oral 2707mg/kg (2707mg/kg) AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC

BEHAVIORAL: MUSCLE WEAKNESS

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Toksikologicheskii Vestnik. Vol. (5), Pg. 41, 1994.
mouse LD50 subcutaneous 737mg/kg (737mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 193, 1973.
rat LD50 intraperitoneal 295mg/kg (295mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 193, 1973.
rat LD50 intravenous 57100ug/kg (57.1mg/kg)   United States Patent Document. Vol. #4026897,
rat LD50 oral 660mg/kg (660mg/kg)   United States Patent Document. Vol. #4026897,
rat LD50 subcutaneous > 2500mg/kg (2500mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 4, Pg. 193, 1973.
women TDLo oral 1600ug/kg (1.6mg/kg) BEHAVIORAL: TREMOR Human & Experimental Toxicology. Vol. 12, Pg. 397, 1993.
women TDLo oral 2240ug/kg (2.24mg/kg) BEHAVIORAL: TREMOR

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP Annals of Emergency Medicine. Vol. 22, Pg. 1474, 1993."
nan,
60-54-8,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 oral 1875mg/kg (1875mg/kg)   ""Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure,"" Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 109, 1982.
mouse LD50 intraperitoneal 120mg/kg (120mg/kg)   ""Index of Antibiotics from Actinomycetes,"" Umezawa, H. et al., eds., Tokyo, Univ. of Tokyo Press, 1967Vol. -, Pg. 134, 1967.
mouse LD50 intravenous 157mg/kg (157mg/kg)   Farmaco, Edizione Scientifica. Vol. 10, Pg. 346, 1955.
mouse LD50 oral 678mg/kg (678mg/kg)   American Journal of Tropical Medicine and Hygiene. Vol. 2, Pg. 254, 1953.
mouse LD50 subcutaneous 400mg/kg (400mg/kg)   ""CRC Handbook of Antibiotic Compounds,"" Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 3, Pg. 42, 1980.
rat LD50 intraperitoneal 310mg/kg (310mg/kg)   Drugs in Japan Vol. 6, Pg. 493, 1982.
rat LD50 intravenous 129mg/kg (129mg/kg)   Antibiotics and Chemotherapy Vol. 4, Pg. 411, 1954.
rat LD50 oral 807mg/kg (807mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
women LDLo multiple routes 310mg/kg (310mg/kg) LIVER: ""JAUNDICE, OTHER OR UNCLASSIFIED""

GASTROINTESTINAL: NAUSEA OR VOMITING New England Journal of Medicine. Vol. 270, Pg. 157, 1964.
women TDLo oral 600mg/kg/15D (600mg/kg) KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED

GASTROINTESTINAL: DECREASED MOTILITY OR CONSTIPATION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Southern Medical Journal. Vol. 71, Pg. 961, 1978."
108050-54-0,
79-57-2,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 220mg/kg (220mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: FOOD INTAKE (ANIMAL)

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Antibiotics and Chemotherapy Vol. 3, Pg. 1015, 1953.
guinea pig LDLo intraperitoneal 2250mg/kg (2250mg/kg)   Antibiotiki. Vol. 20, Pg. 793, 1975.
infant TDLo parenteral 136mg/kg (136mg/kg) MUSCULOSKELETAL: CHANGES IN TEETH AND SUPPORTING STRUCTURES Lancet. Vol. 1, Pg. 827, 1962.
man TDLo oral 114mg/kg/4D (114mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE""

BLOOD: HEMORRHAGE JAMA, Journal of the American Medical Association. Vol. 231, Pg. 734, 1975.
mouse LD50 intraperitoneal 5706mg/kg (5706mg/kg)   Antibiotiki. Vol. 20, Pg. 793, 1975.
mouse LD50 intravenous 140mg/kg (140mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955.
mouse LD50 oral 2240mg/kg (2240mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 1, 1955.
mouse LD50 subcutaneous 700mg/kg (700mg/kg)   ""CRC Handbook of Antibiotic Compounds,"" Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980Vol. 3, Pg. 44, 1980.
rat LD50 intravenous 260mg/kg (260mg/kg)   ""Antibiotics: Origin, Nature, and Properties,"" Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978.
rat LD50 oral 4800mg/kg (4800mg/kg)   ""Antibiotics: Origin, Nature, and Properties,"" Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 501, 1978.
women TDLo oral 24mg/kg/6D-I (24mg/kg) BLOOD: THROMBOCYTOPENIA American Journal of Hematology. Vol. 43, Pg. 333, 1993."
nan,
619-72-7,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 100mg/kg (100mg/kg)   Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. Vol. 19, Pg. 225, 1969.
mouse LD50 oral 140mg/kg (140mg/kg)   Annales Pharmaceutiques Francaises. Vol. 41, Pg. 391, 1983.
rat LD50 oral 30mg/kg (30mg/kg)   Zentralblatt fuer Arbeitsmedizin und Arbeitsschutz. Vol. 19, Pg. 225, 1969."
nan,
82419-36-1,"Toxicity
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 70mg/kg (70mg/kg)   Drugs in Japan Vol. -, Pg. 291, 1995.
dog LD50 oral > 200mg/kg (200mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

GASTROINTESTINAL: ""HYPERMOTILITY, DIARRHEA"" Chemotherapy Vol. 32(Suppl,
man TDLo oral 17mg/kg/3D-I (17mg/kg) SKIN AND APPENDAGES (SKIN): ""DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE""

BEHAVIORAL: EXCITEMENT

BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) Internal Medicine. Vol. 34, Pg. 872, 1995.
man TDLo oral 51428ug/kg (51.428mg/kg) GASTROINTESTINAL: ""HYPERMOTILITY, DIARRHEA"" American Journal of Medicine. Vol. 87, Pg. 479, 1989.
monkey LD50 oral 500mg/kg (500mg/kg)   Chemotherapy Vol. 32(Suppl,
mouse LD50 intramuscular > 600mg/kg (600mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Zhongguo Kangshengsu Zazhi. Chinese Journal of Antibiotics. Vol. 18, Pg. 218, 1993.
mouse LD50 intraperitoneal 805mg/kg (805mg/kg)   Ensho. Japanese Journal of Inflammation. Vol. 11, Pg. 343, 1991.
mouse LD50 intravenous 208mg/kg (208mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: COMA Chemotherapy Vol. 32(Suppl,
mouse LD50 oral 3266mg/kg (3266mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Zhongguo Kangshengsu Zazhi. Chinese Journal of Antibiotics. Vol. 18, Pg. 218, 1993.
mouse LDLo subcutaneous 7690mg/kg (7690mg/kg)   Chemotherapy Vol. 32(Suppl,
rat LD50 intravenous 273mg/kg (273mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: COMA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Chemotherapy Vol. 32(Suppl,
rat LD50 oral 3590mg/kg (3590mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Chemotherapy Vol. 32(Suppl,
rat LD50 subcutaneous 7070mg/kg (7070mg/kg) BEHAVIORAL: ATAXIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Chemotherapy Vol. 32(Suppl,
women TDLo oral 24mg/kg/3D-I (24mg/kg) BEHAVIORAL: TOXIC PSYCHOSIS

BEHAVIORAL: ""HALLUCINATIONS, DISTORTED PERCEPTIONS""

BEHAVIORAL: IRRITABILITY Journal of Clinical Psychiatry. Vol. 53, Pg. 137, 1992."
